Abstract
In a multicentre controlled clinical trial of potassium, glucose, and insulin in the treatment of acute myocardial infarction no significant benefit was shown to be derived from the regimen, the mortality-rate at twenty-eight days in the treated group being 23·9% (98 of 410 patients) and in the control group 25·3% (109 of 430 patients). The incidence of cardiac arrhythmias also was not significantly altered by the treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
